Brief: Immuron Requests Pre-Ind Meeting For Imm-529 With FDA Filing
July 2 (Reuters) - Immuron Ltd IMC.AX :
* IMMURON REQUESTS PRE-IND MEETING FOR IMM-529 WITH FDA
FILING
* FILES PRE-IND APPLICATION WITH FDA FOR IMM-529
Source text for Eikon: ID:nGNX1KDBqv
Further company coverage: IMC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million